Pall T. Onundarson: The Fiix Test Team Was Awarded UNIVANTS 2025!
Pall T. Onundarson, Professor Emeritus at Landspitali University Hospital, proudly reposted from Eduardo Freggiaro on LinkedIn:
”The Fiix test team was awarded UNIVANTS 2025 Team of Distinction and got to meet the UNIVANTS of HealthCare Excellence executives at the ADLM (previously AACC) 2025 in Chicago.
The prize is awarded by 7 important healthcare associations around the world.
These people see the potential of improved patient care through replacing the conventional monitoring method of warfarin and VKAs (PT-INR) with a new test that more accurately reflects the antithrombotic effect, reduces anticoagulation variability and enhances effectiveness of anticoagulation with the old drug class that everybody had written off and thought they knew all about…
But now clinical pharmacology needs some revision.
Fortunately, it is very easy to replace the PT-INR with the Fiix-NR: same instruments, same staff, mostly the same dosing protocols.
The Fiix test is CE marked in Europe, still for scientific use elsewhere, manufactured by Hart Biologicals Limited in England.”
Eduardo Freggiaro, President of FBA, Executive Board member of IFCC, shared an honoring post on LinkedIn:
”During the ADLM congress in Chicago I had the opportunity and honor to participate in this photo with the winners of the highest recognition of the UNIVANTS 2025 award.
Also present were previous winners, Abbott executives and the CEO of the ADLM.
Congratulations to Professor Pall T. Onundarson, M.D. and his team for the excellent work they have done.”
Stay updated on the emerging with Hemostasis Today.
-
Oct 10, 2026, 17:58Archo Farzana Batool: Exploring Medical Writing Through an Article on Iron Deficiency Anemia
-
Oct 10, 2026, 17:53Assessing Frailty in Adults With Hemophilia – JTH
-
Oct 10, 2026, 17:52Fatma Sadeghi: Reducing Maternal Health Inequalities Through Nursing Advocacy
-
Oct 10, 2026, 17:50Grzegorz Hensler: How Apheresis Transformed Blood Cell Separation and Collection
-
Oct 10, 2026, 17:47Hemant K Sharma: Japan’s Universal Artificial Blood Research – A Potential Breakthrough in Transfusion Medicine
-
Oct 10, 2026, 17:40John Strouse: Learning About Bleeding Disorders and Sickle Cell Disease at FWGBD
-
Oct 10, 2026, 17:34Mae Caime: Speaking at the Annual Women’s Retreat for the Hemophilia Community in Florida
-
Oct 10, 2026, 17:30Chokri Ben Lamine: PNH beyond the Textbook Triad
-
Oct 10, 2026, 17:29Ruah Alyamany: Thrombosis and Anticoagulation in Hematological Malignancies at SOHO KSA 2026